The largest exit of an Israeli healthcare company

I reported previously (four times) on Israel’s Neuroderm and its innovative treatments for Parkinson’s sufferers.  Neuroderm has just been bought by Japan’s Mitsubishi Tanabe for $1.1 billion – a record for an Israeli life-science company. It should bring products to market faster.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *